Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Bayer
< Previous
1
2
3
4
5
6
7
Next >
Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology
June 01, 2023
From
Bayer
Via
Business Wire
Bayer Launches Unit to Develop New Precision Health Consumer Products
May 31, 2023
From
Bayer
Via
Business Wire
Bayer Presents New Data Across Oncology Portfolio at the 2023 ASCO Annual Meeting
May 25, 2023
From
Bayer
Via
Business Wire
Bayer launches Seeing Red campaign around the treatment of Heavy Menstrual Bleeding (HMB)
May 16, 2023
From
Bayer
Via
Business Wire
Bayer Receives U.S. FDA Fast Track Designation for asundexian Atrial Fibrillation Program
May 16, 2023
From
Bayer
Via
Business Wire
Boundless Bio Announces $100 Million Oversubscribed Series C Financing co-led by Leaps by Bayer and RA Capital Management to Advance the First ecDNA-Directed Therapies (ecDTx) for Patients with Oncogene Amplified Cancer
May 16, 2023
From
Bayer
Via
Business Wire
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
May 10, 2023
From
Bayer
Via
Business Wire
Tickers
BCYC
Bayer Opens First Co.Lab Life Science Incubator in Cambridge
May 04, 2023
From
Bayer
Via
Business Wire
Bayer Announces New Strategic Collaboration with New Jersey’s Leading Polytechnic Universities to Cultivate Data Science Talent in Region
April 24, 2023
From
Bayer
Via
Business Wire
There Is No Room for Allergy Fog This Spring Allergy Season with Claritin®
April 18, 2023
From
Bayer
Via
Business Wire
Claritin® Takes Aim at Reducing Pollen Levels Through Female Tree Planting Initiative
April 04, 2023
From
Bayer
Via
Business Wire
Astepro® Allergy Partners with Meghann Fahy to Help Allergy Sufferers Conquer Allergies, Love & Spontaneity Fast
March 30, 2023
From
Bayer
Via
Business Wire
Bayer Expands Global Clinical Program for NUBEQA® (darolutamide) in Prostate Cancer
March 23, 2023
From
Bayer
Via
Business Wire
UN 2023 Water Conference: Bayer pledges to help tackle global water crisis with new water strategy
March 21, 2023
From
Bayer
Via
Business Wire
Bayer collaborates with Microsoft to unveil new cloud-based enterprise solutions, advancing innovation and transparency in the agri-food industry
March 14, 2023
From
Bayer
Via
Business Wire
Bayer US Joins the Fight to Combat Water Crisis
March 09, 2023
From
Bayer
Via
Business Wire
World Kidney Day: A Bayer Survey Reveals Physicians Agree on Need for Earlier Testing and Increased Transparent Communication for People Diagnosed With Chronic Kidney Disease Associated With Type 2 Diabetes
March 09, 2023
From
Bayer
Via
Business Wire
Bayer Unveils the Preceon™ Smart Corn System, Transforming How Farmers Manage Their Corn Crop
March 08, 2023
From
Bayer
Via
Business Wire
Bayer Expands its “Nutrient Gap Initiative” to Help End Malnutrition
February 23, 2023
From
Bayer
Via
Business Wire
New NUBEQA® (darolutamide) Subgroup Analyses from the Phase III ARASENS Trial in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Patients Presented at ASCO GU
February 16, 2023
From
Bayer
Via
Business Wire
Bill Anderson to Become CEO of Bayer AG
February 08, 2023
From
Bayer
Via
Business Wire
Bayer Announces First Patients Enrolled in Global Phase III Studies for Investigational Oral FXIa Inhibitor Asundexian
February 08, 2023
From
Bayer
Via
Business Wire
Bayer Announces Full Commercialization of ThryvOn™ Technology in the U.S., a Unique Cotton Biotech Trait Set to Launch for 2023 Growing Season
February 07, 2023
From
Bayer
Via
Business Wire
Bayer® Aspirin Continues Long-standing Commitment to Heart Health Education, Encouraging Sports Fans to Keep Their Heart in the Game as the Official Sponsor of Fans’ Hearts
February 06, 2023
From
Bayer
Via
Business Wire
Phase IIb Clinical Study of Investigational Compound Elinzanetant Evaluated Efficacy and Safety in Postmenopausal Patients with Vasomotor Symptoms Study Findings Published in Menopause: The Journal of The North American Menopause Society
February 02, 2023
From
Bayer
Via
Business Wire
Bayer Appoints Ben Kampelman as Vice President of Communications for Crop Science North America
January 24, 2023
From
Bayer
Via
Business Wire
Bayer Acquires Blackford Analysis Ltd. Bolstering the Company’s Position in Digital Medical Imaging
January 18, 2023
From
Bayer
Via
Business Wire
Bayer to make more than $1.5 Million in Investments in STEAM Education and West Berkeley Resiliency
December 19, 2022
From
Bayer
Via
Business Wire
Bayer Launches Industry-First Public Database Listing Company’s Science Collaborations and Partnerships in the U.S.
December 06, 2022
From
Bayer
Via
Business Wire
2022 Radiological Society of North America (RSNA) Annual Meeting: Bayer to showcase product offerings and announces broadened AI offering in Radiology
November 22, 2022
From
Bayer
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.